Saturday, July 27, 2024
HomeBusinessNew Covid study hints at long-term loss of brain tissue, Dr. Scott...

New Covid study hints at long-term loss of brain tissue, Dr. Scott Gottlieb warns

Date:

Related stories

Guide to Using Essential Oils for Skincare

Essential oils are famous for skincare. They come from...

Signage for businesses – Services and their benefits

Signage is a form of advertising that conveys the...

OPSC Recruitment 2024: Apply Online for Latest Vacancies

The Odisha Public Service Commission (OPSC) has announced its...

Why It’s Important for Teachers to Teach Social and Emotional Skills

Academic knowledge alone is not enough to prepare students...

How Religion Supports and Shields Children’s Mental Health

In the UK today, many parents and foster carers...

[ad_1]

Dr. Scott Gottlieb warned Thursday about the potential for long-term brain loss associated with Covid, citing a new study from the United Kingdom.

“In short, the study suggests that there could be some long-term loss of brain tissue from Covid, and that would have some long-term consequences,” the former FDA chief and CNBC contributor said. 

 “You could compensate for that over time, so the symptoms of that may go away, but you’re never going to regain the tissue if, in fact, it’s being destroyed as a result of the virus,” said Gottlieb, who serves on the board of Covid vaccine-maker Pfizer.

The U.K. study examined brain imaging before and after a coronavirus infection and looked specifically at the potential effect on the nervous system. 

Gottlieb explained to CNBC’s “The News with Shepard Smith” that the destruction of brain tissue could explain why Covid patients lost their sense of smell. 

“The diminishment in the amount of cortical tissue happened to be in regions of the brain that are close to the places that are responsible for smell,” he said. “What it suggests is that, the smell, the loss of smell, is just an effect of a more primary process that’s underway, and that process is actually shrinking of cortical tissue.” 

Disclosure: Scott Gottlieb is a CNBC contributor and is a member of the boards of Pfizer, genetic testing start-up Tempus, health-care tech company Aetion Inc. and biotech company Illumina.

[ad_2]

Source link

See also  Boeing, Intellia Therapeutics, Perion Network & more
Bellie Brown
Bellie Brownhttps://businesstimes.org
Hi my lovely readers, I am Bellie brown editor and writer of Businesstimes.org. I write blogs on various niches such as business, technology, lifestyle., health, entertainment, etc as well as manage the daily reports of the website. I am very addicted to my work which makes me keen on reading and writing on the very latest and trending topics. One can check my more writings by visiting Cleartips.net

Latest stories